Skip to main content

Advertisement

SpringerLink
Log in

Comparison of adult versus embryonic stem cell therapy for cardiovascular disease: Insights from molecular imaging studies

  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

In the previous decade, cardiac cell replacement therapy has emphasized adult stem cells such as skeletal myoblasts, bone marrow mononuclear cells, and endothelial progenitor cells. Functional restoration of systolic function has been documented in most of these cases, but beneficial results have rarely persisted for significant lengths of time due to failure of cells to survive and the as yet controversial role of transdifferentiation into endogenous tissue. Future efforts at cell replacement therapy will likely focus upon cellular derivatives of embryonic stem (ES) cells, which can be induced to form any cell type of the body. Use of ES cells, however, presents several novel considerations such as teratoma formation and immune rejection. This review summarizes the current progress made in the field of cardiac cell replacement therapy and the role noninvasive imaging can play in realizing the therapeutic potential of stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25–e146.

    Article  PubMed  Google Scholar 

  2. Rosenzweig A: Cardiac cell therapy—mixed results from mixed cells. N Engl J Med 2006, 355:1274–1277.

    Article  PubMed  CAS  Google Scholar 

  3. Chiu RC, Zibaitis A, Kao RL: Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995, 60:12–18.

    PubMed  CAS  Google Scholar 

  4. Taylor DA, Atkins BZ, Hungspreugs P, et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998, 4:929–933.

    Article  PubMed  CAS  Google Scholar 

  5. Leobon B, Garcin I, Menasche P, et al.: Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003, 100:7808–7811.

    Article  PubMed  CAS  Google Scholar 

  6. Hagege AA, Carrion C, Menasche P, et al.: Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003, 361:491–492.

    Article  PubMed  Google Scholar 

  7. Tomita S, Li RK, Weisel RD, et al.: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999, 100(Suppl 19):II247–II256.

    PubMed  CAS  Google Scholar 

  8. Orlic D, Kajstura J, Chimenti S, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701–705.

    Article  PubMed  CAS  Google Scholar 

  9. Jackson KA, Majka SM, Wang H, et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001, 107:1395–1402.

    Article  PubMed  CAS  Google Scholar 

  10. Murry CE, Soonpaa MH, Reinecke H, et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664–668.

    Article  PubMed  CAS  Google Scholar 

  11. Balsam LB, Wagers AJ, Christensen JL, et al.: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668–673.

    Article  PubMed  CAS  Google Scholar 

  12. Kamihata H, Matsubara H, Nishiue T, et al.: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046–1052.

    Article  PubMed  CAS  Google Scholar 

  13. Kalka C, Masuda H, Takahashi T, et al.: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422–3427.

    Article  PubMed  CAS  Google Scholar 

  14. Takamiya M, Okigaki M, Jin D, et al.: Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006, 26:751–757.

    Article  PubMed  CAS  Google Scholar 

  15. Asahara T, Murohara T, Sullivan A, et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964–967.

    Article  PubMed  CAS  Google Scholar 

  16. Takahashi T, Kalka C, Masuda H, et al.: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434–438.

    Article  PubMed  CAS  Google Scholar 

  17. Kocher AA, Schuster MD, Szabolcs MJ, et al.: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430–436.

    Article  PubMed  CAS  Google Scholar 

  18. Pittenger MF, Martin BJ: Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9–20.

    Article  PubMed  CAS  Google Scholar 

  19. Pittenger MF, Mackay AM, Beck SC, et al.: Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143–147.

    Article  PubMed  CAS  Google Scholar 

  20. Jiang Y, Jahagirdar BN, Reinhardt RL, et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41–49.

    Article  PubMed  CAS  Google Scholar 

  21. Tse WT, Pendleton JD, Beyer WM, et al.: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389–397.

    Article  PubMed  CAS  Google Scholar 

  22. Le Blanc K, Frassoni F, Ball L, et al.: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579–1586.

    Article  PubMed  Google Scholar 

  23. Barbash IM, Chouraqui P, Baron J, et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863–868.

    Article  PubMed  Google Scholar 

  24. Vulliet PR, Greeley M, Halloran SM, et al.: Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004, 363:783–784.

    Article  PubMed  Google Scholar 

  25. Swijnenburg RJ, Schrepfer S, Govaert JA, et al.: Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A 2008, 105:12991–12996.

    Article  PubMed  CAS  Google Scholar 

  26. Swijnenburg RJ, Schrepfer S, Cao F, et al.: In vivo imaging of embryonic stem cells reveals patterns of survival and rejection following transplantation. Stem Cells Dev 2008, 17:1023–1030.

    Article  PubMed  CAS  Google Scholar 

  27. Maitra A, Arking DE, Shivapurkar N, et al.: Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005, 37:1099–1103.

    Article  PubMed  CAS  Google Scholar 

  28. Xu C, Police S, Rao N, et al.: Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002, 91:501–508.

    Article  PubMed  CAS  Google Scholar 

  29. Kolossov E, Bostani T, Roell W, et al.: Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006, 203:2315–2327.

    Article  PubMed  CAS  Google Scholar 

  30. Cao F, Wagner RA, Wilson KD, et al.: Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE 2008, 3:e3474.

    Article  PubMed  Google Scholar 

  31. He JQ, Ma Y, Lee Y, et al.: Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003, 93:32–39.

    Article  PubMed  CAS  Google Scholar 

  32. Xue T, Cho HC, Akar FG, et al.: Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111:11–20.

    Article  PubMed  Google Scholar 

  33. van Laake LW, Passier R, Doevendans PA, et al.: Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008, 102:1008–1010.

    Article  PubMed  Google Scholar 

  34. Laflamme MA, Chen KY, Naumova AV, et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015–1024.

    Article  PubMed  CAS  Google Scholar 

  35. Li Z, Wu JC, Sheikh AY, et al.: Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116(Suppl 11):I46–I54.

    PubMed  Google Scholar 

  36. Wang ZZ, Au P, Chen T, et al.: Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007, 25:317–318.

    Article  PubMed  CAS  Google Scholar 

  37. Meyer GP, Wollert KC, Lotz J, et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial. Circulation 2006, 113:1287–1294.

    Article  PubMed  Google Scholar 

  38. Assmus B, Honold J, Schachinger V, et al.: Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222–1232.

    Article  PubMed  CAS  Google Scholar 

  39. Lunde K, Solheim S, Aakhus S, et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199–1209.

    Article  PubMed  CAS  Google Scholar 

  40. Schachinger V, Erbs S, Elsasser A, et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210–1221.

    Article  PubMed  CAS  Google Scholar 

  41. Menasche P, Alfieri O, Janssens S, et al.: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189–1200.

    Article  PubMed  Google Scholar 

  42. Kraitchman DL, Heldman AW, Atalar E, et al.: In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290–2293.

    Article  PubMed  Google Scholar 

  43. Amado LC, Saliaris AP, Schuleri KH, et al.: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005, 102:11474–11479.

    Article  PubMed  CAS  Google Scholar 

  44. Hofmann M, Wollert KC, Meyer GP, et al.: Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198–2202.

    Article  PubMed  Google Scholar 

  45. Li Z, Suzuki Y, Huang M, et al.: Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26:864–873.

    Article  PubMed  CAS  Google Scholar 

  46. Cao F, Lin S, Xie X, et al.: In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006, 113:1005–1014.

    Article  PubMed  Google Scholar 

  47. van der Bogt KE, Sheikh AY, Schrepfer S, et al.: Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008, 118(Suppl 14):S121–S129.

    Article  PubMed  Google Scholar 

  48. Gyöngyösi M, Marian T, Trón L, et al.: Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging 2008, 1:94–103.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University School of Medicine, Edwards Building R354, Stanford, CA, 94305, USA

    Joseph C. Wu

Authors
  1. Andrew S. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph C. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph C. Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, A.S., Wu, J.C. Comparison of adult versus embryonic stem cell therapy for cardiovascular disease: Insights from molecular imaging studies. curr cardiovasc imaging rep 2, 50–58 (2009). https://doi.org/10.1007/s12410-009-0007-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12410-009-0007-8

Keywords

Search

Navigation